​Dr. Cheng is the Alan L. Kaganov Professor of Biomedical Engineering at Columbia University. Prior to that, he was the Randall B. Terry, Jr. Distinguished Professor of Regenerative Medicine at the UNC/NC State Joint Department of Biomedical Engineering. He served as the Chair of the NIH Biomaterials and Biointerfaces (BMBI) study section (2022-2024). He also co-directed the NIH Comparative Molecular Medicine T32 Training Program and served as the Executive Director of Interdisciplinary Scholarship in NC State’s Office of the Provost. He is one of the “2023 highly cited researchers” based on Clarivate. Research from Dr. Cheng’s lab has been summarized in publications in Nature Materials, Nature Nanotechnology, Nature Biomedical Engineering, Science Translational Medicine, Circulation Research, European Heart Journal, and more. Dr. Cheng is a fellow of the Biomedical Engineering Society (BMES), International Association of Medical and Biological Engineering (IAMBE), the American Institute of Medical and Biological Engineering (AIMBE), and the American Heart Association (AHA). Additionally, he currently serves as the Editor-in-Chief for Extracellular Vesicle (Elsevier) and Associate Editor for Bioactive Materials. Dr. Cheng has been devoted to the clinical application of stem cells and exosomes. He led several Investigational New Drug (IND) applications obtained from the FDA. The biotech companies he founded are developing cell and extracellular vesicle therapies, biomaterials, and devices to provide better solutions for lung and heart regeneration, cancer therapy, and drug delivery.